• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    413.48 Up 13.36(3.34%) Dec 26, 4:00PM EST
    |After Hours : 415.00 Up 1.52 (0.37%) Dec 26, 5:27PM EST
    Add to Portfolio
    Prev Close:400.12
    Open:403.45
    Bid:N/A
    Ask:418.03 x 100
    1y Target Est:407.65
    Beta:1.62
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:402.12 - 414.84
    52wk Range:262.97 - 437.64
    Volume:722,479
    Avg Vol (3m):831,236
    Market Cap:41.68B
    P/E (ttm):141.36
    EPS (ttm):2.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    REGNUp 3.34%41.68B
    AMGNUp 1.74%124.34B
    NVSUp 0.20%227.60B
    RHHBYDown 0.16%232.56B

    Key Statistics

    Forward P/E (1 yr):35.22
    P/S (ttm):15.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :9.97
    Quarterly EPS Est (Dec-14) :2.75
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.99

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback